Sigma Healthcare (Sigma Healthcare) Buyback Yield % : -19.65 (As of May. 15, 2024)

View and export this data going back to 2009. Start your Free Trial

What is Sigma Healthcare Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Sigma Healthcare's current buyback yield was -19.65%.

Sigma Healthcare Buyback Yield % Historical Data

The historical data trend for Sigma Healthcare's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sigma Healthcare Buyback Yield % Chart

Sigma Healthcare Annual Data

Trend

Jan15

Jan16

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

Jan24

Buyback Yield %

Get a 7-Day Free Trial

-0.57

-0.05

-0.02

-0.10

-40.27

Sigma Healthcare Semi-Annual Data
	Jul14	Jan15	Jul15	Jan16	Jul16	Jan17	Jul17	Jan18	Jul18	Jan19	Jul19	Jan20	Jul20	Jan21	Jul21	Jan22	Jul22	Jan23	Jul23	Jan24
Buyback Yield %	Get a 7-Day Free Trial															0.02	-0.07	-0.13	-0.29	-80.28

Competitive Comparison of Sigma Healthcare's Buyback Yield %

For the Medical Distribution subindustry, Sigma Healthcare's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sigma Healthcare's Buyback Yield % Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sigma Healthcare's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Sigma Healthcare's Buyback Yield % falls into.

Sigma Healthcare Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Sigma Healthcare's Buyback Yield for the fiscal year that ended in Jan. 2024 is calculated as

Buyback Yield	=	Net Issuance of Stock			/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	/	Market Cap
	=	- (0	+	262.851)	/	652.748
	=	-40.27%

Sigma Healthcare's annualized Buyback Yield for the quarter that ended in Jan. 2024 is calculated as

Buyback Yield	=	Net Issuance of Stock		(Annualized)			/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	*	Annualized Factor	/	Market Cap
	=	- (0	+	262.023)	*	2	/	652.748
	=	-80.28%

In calculating the annualized semi-annual data, the Repurchase of Stock and Issuance of Stock data used here is two times the semi-annual (Jan. 2024) data.

Sigma Healthcare Buyback Yield % Related Terms

Thank you for viewing the detailed overview of Sigma Healthcare's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Sigma Healthcare (Sigma Healthcare) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sigma Healthcare Ltd (OTCPK:SIGGF) » Definitions » Buyback Yield %

Comparable Companies

Traded in Other Exchanges

S5YA:Germany SIG:Australia

Address

2125 Dandenong Road, Level 6, Clayton, Melbourne, VIC, AUS, 3168

Website

https://www.sigmahealthcare.com.au

Sigma Healthcare is an Australian pharmaceutical distributor, wholesaler and pharmacy franchisor. The revenue growth prospects and returns of pharmaceutical distribution are subdued due to ongoing Pharmaceutical Benefits Scheme, or PBS, price reform, and regulated wholesale gross margins being capped at 7% for community pharmacy. As a result, Sigma and its competitors are seeking to expand into unregulated revenue streams. In addition, pharmacy ownership is restricted to pharmacists, thereby excluding direct corporate ownership and requiring exposure via a franchise business model.